ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.283,62
0,00%
S&P 500
5.297,10
-0,21%
US Dollar vs BRL
5,12987
0,00%
Bitcoin
66.246,16
1,54%
Brent Oil
83,115
-0,11%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Applied Molecular Transport Inc (AMTI)

  7. Applied Molecular Transport Inc (AMTI) Notícias

AMTI

Applied Molecular Transp... (AMTI)

Applied Molecular Transport Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMTI
DataHoraFonteTítuloCódigoCompanhia
09/01/202408:12Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:AMTIApplied Molecular Transport Inc
03/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202411:15Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202411:14Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AMTIApplied Molecular Transport Inc
02/01/202411:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:AMTIApplied Molecular Transport Inc
28/12/202319:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMTIApplied Molecular Transport Inc
27/12/202318:15Business WireCyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.NASDAQ:AMTIApplied Molecular Transport Inc
27/12/202317:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMTIApplied Molecular Transport Inc
15/12/202318:06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AMTIApplied Molecular Transport Inc
21/11/202311:16Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AMTIApplied Molecular Transport Inc
09/11/202318:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMTIApplied Molecular Transport Inc
09/11/202318:01GlobeNewswire Inc.Applied Molecular Transport Reports Third Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
27/09/202312:47Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:AMTIApplied Molecular Transport Inc
21/09/202309:05Business WireCyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger AgreementNASDAQ:AMTIApplied Molecular Transport Inc
14/08/202317:01GlobeNewswire Inc.Applied Molecular Transport Reports Second Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
15/06/202318:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMTIApplied Molecular Transport Inc
15/06/202317:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AMTIApplied Molecular Transport Inc
08/06/202317:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AMTIApplied Molecular Transport Inc
11/05/202317:05GlobeNewswire Inc.Applied Molecular Transport Reports First Quarter 2023 Financial ResultsNASDAQ:AMTIApplied Molecular Transport Inc
28/04/202317:30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AMTIApplied Molecular Transport Inc
27/03/202317:01GlobeNewswire Inc.Applied Molecular Transport Announces Corporate Leadership Change and Process to Explore Strategic AlternativesNASDAQ:AMTIApplied Molecular Transport Inc
09/03/202318:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AMTIApplied Molecular Transport Inc
09/03/202318:05GlobeNewswire Inc.Applied Molecular Transport Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:AMTIApplied Molecular Transport Inc
03/03/202310:00GlobeNewswire Inc.Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 CongressNASDAQ:AMTIApplied Molecular Transport Inc
09/02/202318:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AMTIApplied Molecular Transport Inc
22/12/202219:30GlobeNewswire Inc.Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative ColitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202211:10Dow Jones NewsApplied Molecular Transport Gets New FDA Orphan Drug DesignationNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202210:00GlobeNewswire Inc.Applied Molecular Transport Announces FDA Orphan Drug Designation Granted to AMT-101 for Treatment of PouchitisNASDAQ:AMTIApplied Molecular Transport Inc
10/11/202201:25TipRanksSVB Securities Remains a Buy on Applied Molecular Transport (AMTI)NASDAQ:AMTIApplied Molecular Transport Inc
08/11/202210:00GlobeNewswire Inc.Applied Molecular Transport to Present at Upcoming November Investor ConferencesNASDAQ:AMTIApplied Molecular Transport Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AMTI

Seu Histórico Recente

LSE
GI32
Citi Fun 24
ASX
CRV
EU
WCAMG
Euronext World Sustainable
BIT
UC6102
Unicredit Bank
ASX
CMJ
Consolidated Media Holdings
LSE
LO53
Citi Fun 26
EU
ALLIX
Wallix
HUOB
JSTETH
JUST
BIT
F36485
Vontobel Financial Produ...
COIN
ORYXGBP
COIN
TARAEUR
Taraxa Coin
LSE
BF13
Cred Ag Co 31
BIT
UC79XB
Unicredit Bank
LSE
61WG
City Gotebg 26
NASDAQ
CRNX
Crinetics Pharmaceuticals
BTRX
WEMIXUSDT
WEMIX TOKEN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados